Cancer treatment during childhood linked to cognitive problems later in life

June 14, 2017, KU Leuven

Young adults who had chemotherapy as a child have decreased cognitive flexibility and a weaker short-term memory. Their ability to concentrate and long-term memory are largely unaffected. Researchers from KU Leuven (University of Leuven) and University Hospitals Leuven present these findings in the Journal of the National Cancer Institute.

The researchers examined 31 who underwent chemotherapy as a child - on average around the age of six and a half. They compared these survivors' performance on a number of psychological tests with the results of a control group.

The results show that cognitive functions such as and the ability to concentrate are largely unaffected. These skills had already developed before the treatment. But the cancer treatment has an impact on several skills developed later on.

Slowly developing functions, in particular, are very vulnerable. "Tests that require quick switching between tasks or remembering new information for a short amount of time were clearly more difficult for former cancer patients. The developmental stage of the brain at the start of the cancer treatment probably plays a decisive role," psychiatrist in training Iris Elens and Professor Rudi D'Hooge explain.

The researchers also found a link between cognitive performance and the levels of one particular protein in the brain fluid: phosphorylated Tau (p-Tau), which is part of the internal structure of our nerve cells.

"Our team collected samples of brain fluid during the . We analysed the p-Tau levels to measure the damage to the brain cells," Professor D'Hooge explains. "We found that high concentrations of p-Tau predict cognitive problems at a later age."

"If we systematically measure these p-Tau levels in the future," Iris Elens continues, "we can offer specific help to children with high values. With early coaching aimed at the most relevant functions we can prevent problems that would otherwise manifest 10 to 15 years after the treatment."

Explore further: Can training your working memory make you smarter?

More information: Iris Elens et al, Neurocognitive Sequelae in Adult Childhood Leukemia Survivors Related to Levels of Phosphorylated Tau, JNCI: Journal of the National Cancer Institute (2017). DOI: 10.1093/jnci/djw321

Related Stories

Can training your working memory make you smarter?

March 10, 2017
We would all like to boost our cognitive ability beyond the limits set by Mother Nature. So it's no wonder that brain-training programmes – which typically focus on training our working memory – are a multibillion-dollar ...

Post-traumatic stress affects cognitive function in cancer patients

May 4, 2017
Subtle cognitive dysfunction and decline in breast cancer patients was largely independent of chemotherapy but associated with cancer-related post-traumatic stress in a German multisite study.

Cognitive-behavioral therapy may help reduce memory problems in cancer survivors who have received chemotherapy

May 2, 2016
A new analysis indicates that a type of psychotherapy delivered by videoconference may help prevent some of the long-term memory issues caused by chemotherapy. Published early online in CANCER, a peer-reviewed journal of ...

Memory problems after chemo linked to brain changes

May 29, 2014
(HealthDay News)—Breast cancer survivors who had chemotherapy show changes in brain activity during multitasking chores, according to a new Belgian study.

No risk association observed for anthracycline chemotherapy, cognitive decline

April 21, 2016
New data analyses found no association between anthracycline chemotherapy and greater risk of cognitive decline in breast cancer survivors, according to an article published online by JAMA Oncology.

New clues about the aging brain's memory functions

June 29, 2016
A European study led by Umeå University Professor Lars Nyberg, has shown that the dopamine D2 receptor is linked to the long-term episodic memory, which function often reduces with age and due to dementia. This new insight ...

Recommended for you

Brain aging may begin earlier than expected

February 20, 2018
Physicists have devised a new method of investigating brain function, opening a new frontier in the diagnoses of neurodegenerative and ageing related diseases.

Brain immune system is key to recovery from motor neuron degeneration

February 20, 2018
The selective demise of motor neurons is the hallmark of Lou Gehrig's disease, also known as amyotrophic lateral sclerosis (ALS). Yet neurologists have suspected there are other types of brain cells involved in the progression ...

Every experience that the brain perceives is unique

February 20, 2018
Neuronal activity in the prefrontal cortex represents every experience as "novel." The neurons adapt their activity accordingly, even if the new experience is very similar to a previous one. That is the main finding of a ...

Electrical implant reduces 'invisible' symptoms of man's spinal cord injury

February 19, 2018
An experimental treatment that sends electrical currents through the spinal cord has improved "invisible" yet debilitating side effects for a B.C. man with a spinal cord injury.

Lab-grown human cerebellar cells yield clues to autism

February 16, 2018
Increasing evidence has linked autism spectrum disorder (ASD) with dysfunction of the brain's cerebellum, but the details have been unclear. In a new study, researchers at Boston Children's Hospital used stem cell technology ...

Fragile X syndrome neurons can be restored, study shows

February 16, 2018
Fragile X syndrome is the most frequent cause of intellectual disability in males, affecting one out of every 3,600 boys born. The syndrome can also cause autistic traits, such as social and communication deficits, as well ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.